Vericel reports Q3 2023 revenue of $45.6M (+18% YoY), raises FY guidance

Vericel Corp

2023-Q3 EPS reported -$0.34 revenue$132,520,000

Total revenue $45.6M (+18% YoY); MACI revenue $37.6M (+21% YoY).
Net loss $3.7M ($0.08/sh); adjusted EBITDA $5.4M (12% of revenue).
FY2023 revenue guidance raised to $192.5-197.5M from prior $190-197M.
Cash $149M, no debt; 13th consecutive quarter of positive adjusted EBITDA and operating cash flow.
MACI arthroscopic delivery launch expected H1 2024; NexoBrid commercially launched.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.